[
    "\n<p><strong>Preparation of culture medium</strong></p><p><strong>a.&nbsp;&nbsp;</strong>&nbsp;&nbsp;Naïve hPSC culture media</p><p><strong>1.&nbsp;</strong>&nbsp;&nbsp;5iLA medium<sup>2</sup> was prepared using the following: 1:1 (v/v) mixture of DMEM/F12 and Neurobasal medium, 1X N2 supplement, 1X B27 supplement, 1X GlutaMAX, 1X MEM Non-Essential Amino Acids, 0.1 mM β-mercaptoethanol, 0.5% Penicillin-Streptomycin, 50 mg/mL BSA, 1 μM PD0325901, 0.5 μM IM-12, 0.5 μM SB590885, 1 μM WH-4-023, 20 ng/mL recombinant human LIF, 10 ng/mL Activin A, and 5 μM Y27632.</p><p><strong>2.&nbsp;</strong>&nbsp;&nbsp;&nbsp;PXGL medium<sup>3</sup> was prepared using the following: 1:1 (v/v) mixture of DMEM/F12 and Neurobasal medium, 1X N2 supplement, 1X B27 supplement, 1X GlutaMAX, 1X MEM Non-Essential Amino Acids, 0.1 mM β-mercaptoethanol, 0.5% Penicillin-Streptomycin, 1 μM PD0325901, 2 μM XAV939, 2 μM Gö6983, and 20 ng/mL recombinant human LIF.</p><p><strong>b.&nbsp;</strong>&nbsp;&nbsp;&nbsp;Human trophoblast stem cell medium (hTSM)</p><p>The hTSM<sup>4</sup> was prepared by including the following: DMEM/F12 supplemented with 0.1 mM β-mercaptoethanol, 0.2% fetal bovine serum, 0.5% Penicillin-Streptomycin, 0.3% BSA, 1% ITS-X, 1.5 μg/ml L-ascorbic acid, 50 ng/ml EGF, 2 μM CHIR99021, 0.5 μM A83-01, 1 μM SB431542 and 0.8 mM VPA.</p><p><strong>c.&nbsp;</strong>&nbsp;&nbsp;&nbsp;Hypoblast differentiation medium (HDM)</p><p>HDM was prepared using the following: 1:1 (v/v) mixture of DMEM/F12 and Neurobasal medium, 1X N2 supplement, 1X B27 supplement, 1X GlutaMAX, 1X MEM Non-Essential Amino Acids, 0.1 mM β-mercaptoethanol, 0.5% Penicillin-Streptomycin, 20 ng/mL bFGF, 20 ng/mL Activin A, and 3 μM CHIR99021.</p><p><strong>d.&nbsp;</strong>&nbsp;&nbsp;Trophoblast differentiation medium (TDM)</p><p>TDM was prepared using the following: 1:1 (v/v) mixture of DMEM/F12 and Neurobasal medium, 0.5X N2 supplement, 0.5X B27 supplement, 0.5% ITS-X, 0.5X GlutaMAX, 0.5X MEM Non-Essential Amino Acids, 0.1 mM β-mercaptoethanol, 0.5% KSR, 0.1% FBS, 50 mg/ml BSA, 0.5% Penicillin-Streptomycin, 1 μM PD0325901, 0.5 μM A83-01, 0.25 μM SB590885, 0.5 μM WH-4-023, 0.25 μM IM-12, 1 μM CHIR99021, 0.5 μM SB431542, 10 ng/mL recombinant human LIF, 25 ng/ml EGF, 0.75 μg/ml L-ascorbic acid, and 0.4 mM VPA.</p><p><strong>Conversion and culture of Naïve hPSCs</strong></p><p><strong>a.&nbsp;&nbsp;</strong>&nbsp;&nbsp;Naïve hPSC conversion: The conversion of preexisting primed hPSCs to naïve hPSCs has been described previously<sup>2,5</sup>. Briefly, 2 × 10<sup>5</sup> primed cells were plated onto a MEF feeder layer in mTeSR1 medium supplemented with 10 μM ROCK inhibitor Y-27632. Two days later, the medium was changed to 5iLA medium. After ~10 days, dome-shaped naive colonies were manually picked and transferred to a fresh MEF plate for further cultivation in 5iLA medium.</p><p><strong>b.</strong>&nbsp;&nbsp;&nbsp;Naïve hPSC culture: Naive hPSCs were cultured on mitomycin C-inactivated MEF feeder cells in 5iLA or PXGL media as described previously<sup>2,3</sup>.</p><p><strong>Note:</strong> The quality of starting naïve hPSCs is critical for human blastoid generation. Typical naïve colonies are shown in <strong>Figure 1</strong>. Prior to blastoid generation, it’s important to first verify the naïve hPSCs have the following features:",
    {
        "title": "1)",
        "body": "dome-shaped colony morphology;"
    },
    {
        "title": "2)",
        "body": "the expression of several key naïve pluripotency markers, e.g. KFL17, SUSD2, TFCP2L1;"
    },
    {
        "title": "3)",
        "body": "a normal karyotype;"
    },
    {
        "title": "4)",
        "body": "normal growth rate; and"
    },
    {
        "title": "5)",
        "body": "the competency for extra-embryonic lineages via monolayer differentiation (described below). </p><p><strong>Monolayer differentiation of naïve hPSCs</strong></p><p><strong>1. </strong>  Prepare 6-well culture plates coated with a 0.2% gelatin solution and incubate at 37°C for at least 30 min before preparing the cells.</p><p><strong>2. </strong>  At ~60% confluency, dissociate naïve hPSCs into single cells by incubating in TrypLE Express solution at 37 °C for ~3 min.</p><p><strong>3.</strong>   Resuspend the cells in 5iLA or PXGL media and centrifuge at 200 g for 3 min.</p><p><strong>4.  </strong> Remove the supernatant and resuspend cells in 2 mL of 5iLA or PXGL media.</p><p><strong>5.   </strong>Transfer the cell suspension into the prepared gelatin-coated 6-well plate and incubate at 37 °C for 30 min to remove MEF cells.</p><p><strong>6. </strong>  Collect and re-plate the supernatant containing naïve hPSCs into a 12-well plate (1 × 10<sup>5</sup> cells/well*) pre-coated with Matrigel in 5iLA or PXGL media.</p><p><strong>*Note:</strong> The plating cell number will need to be increased if the cell variability is found low.</p><p><strong>7. </strong>  HDM followed by hTSM method: after 1 day of culture in 5iLA or PXGL media, change the medium to HDM and culture for an additional 3 days, then change the medium to hTSM and culture for an additional 6 days.</p><p><strong>8.</strong>   hTSM followed by HDM method: after 1 day of culture in 5iLA or PXGL media, change the medium to hTSM and culture for 6 days, then change the medium to HDM and culture for 3 days.</p><p><strong>9.</strong>   Confirm lineage marker expression after 9 days of differentiation by immunostaining. A representative co-staining image is shown in <strong>Figure 2</strong>.</p><p><strong>Note:</strong> We suggest using the following antibodies to verify lineage differentiation: epiblast (SOX2, OCT4, and KLF17), trophoblast (GATA3, GATA2, or TFAP2C), and hypoblast (GATA6, GATA4, and SOX17). After 9 days of differentiation, we found >20% of cells were either GATA3<sup>+</sup> or GATA6<sup>+</sup>.</p><p><strong>Generation of human blastoids</strong></p><p><strong>1.</strong>   Prepare 6-well culture plates coated with a 0.2% gelatin solution and incubate at 37 °C for at least 30 min before using.</p><p><strong>2.</strong>   Prepare an AggreWell™400 plate according to manufacturer instructions. Briefly, add anti-adhesion rinsing solution to the wells, centrifuge at 2,000 g for 5 min, and then incubate at room temperature for at least 10 min.</p><p><strong>3.</strong>   At ~60% confluency, dissociate naïve hPSCs into single cells by incubating cells in TrypLE Express solution at 37 °C for ~3 min.</p><p><strong>4. </strong>  Resuspend the cells in 5iLA or PXGL media and centrifuge at 200 g for 3 min.</p><p><strong>5. </strong>  Remove the supernatant and resuspend the cells in 2 mL of 5iLA or PXGL media.</p><p><strong>6. </strong>  Transfer the cell suspension into a gelatin coated 6-well plate and incubate at 37 °C for 30 min to remove MEF cells.</p><p><strong>7.</strong>   Collect the supernatant containing naïve hPSCs and filter them through a 40 μm cell strainer.</p><p><strong>8. </strong>  Remove the anti-adhesion rinsing solution from the Aggrewell™400, wash the wells with 5iLA or PXGL media once, and then add 0.5 mL of 5iLA or PXGL media to each well.</p><p><strong>9.</strong>   Count the number of naïve hPSCs, and transfer ~30,000 cells (~25 cells/microwell)* to 1 mL of 5iLA or PXGL media.</p><p><strong>*Note:</strong> The starting cell number needs to be optimized for different naïve hPSC lines.</p><p><strong>10.</strong> Transfer 1 mL of the cell suspension (from step"
    },
    {
        "title": "9)",
        "body": [
            "into one well of a prepared Aggrewell™400 plate (from step",
            {
                "title": "8).",
                "body": [
                    "The total volume in the well should now be 1.5 mL.</p><p><strong>11.</strong> Centrifuge the Aggrewell plate at 100 g for 1 min and place it in an incubator maintained at 37 °C and 5% CO<sub>2</sub>. Proceed to step 12 (HT method) or step 15 (TH method).</p><p>Steps 12-14 describe the HT method (HDM followed by TDM):</p><p><strong>12.</strong> After 12 hours of culture, carefully remove as much 5iLA or PXGL media from the well as possible, and then add 1.5 mL of HDM. This is designated as day",
                    {
                        "title": "1.",
                        "body": "Replace with fresh HDM media on day 2.</p><p><strong>Note:</strong> Great care should be taken when working with the Aggrewell™400 in order to avoid flushing aggregates out of the microwells (i.e. aspirate/pipette slowly and carefully).</p><p><strong>13.</strong> After 2-3* days of culture in HDM, carefully remove as much medium as possible, and then add 1 mL of TDM. Then carefully remove as much medium as possible (in order to completely remove HDM) (this can be repeated for 1-2 more times). Finally, add 1.5 mL of fresh TDM to the well. Replace media with fresh TDM every other days.</p><p><strong>*Note:</strong> In our hands, there was no noticeable difference in blastoid formation efficiency when using 2 days vs. 3 days of HDM treatment.</p><p><strong>14.</strong> After 6-8* days of culture in TDM, cavity structures can be observed in some microwells.</p><p><strong>*Note:</strong> The time to generate cavity-containing structures may vary between cell lines, starting naïve hPSC culture conditions, starting cell number, and batches. Longer culture time in TDM may improve cavity structure formation.</p><p>Steps 15-16 describe the TH method (TDM followed by HDM):</p><p><strong>15.</strong> After 12 hours of culture, carefully remove as much 5iLA or PXGL media from the well as possible, and then add 1.5 mL of TDM. This is designated as day"
                    },
                    {
                        "title": "1.",
                        "body": "Replace with fresh TDM media every other days.</p><p><strong>16.</strong> After 6-8* days of culture in TDM cavity structures can be observed in some microwells. Carefully remove as much medium as possible and then add 1 mL of HDM. Then carefully remove as much medium as possible (in order to completely remove TDM) (this can be repeated for 1-2 more times). Finally, add 1.5 mL of fresh HDM to the well and culture for an additional 1-2 days.</p><p><strong>*Note:</strong> The time of TDM treatment may vary as mentioned in step"
                    },
                    {
                        "title": "14.",
                        "body": "Longer culture time in TDM may improve cavity structure formation. In our hands, there was no noticeable difference in blastoid formation efficiency when using 1 days vs. 2 days of HDM treatment with the TH method.</p><p><strong>17.</strong> Once cavity-containing structures have formed, harvest all cell aggregates from the microwells by gently pipetting up and down for 1–2 times with a 1000 uL pipette tip*.</p><p><strong>*Note:</strong> To minimize shearing force from pipetting, cut ~1 mm off the 1000 uL pipette tip with a sterile scissor in the culture hoood before using.</p><p><strong>18.</strong> Transfer all cell aggregates into one well of a 6-well plate, and then manually isolate aggregates with a discernible blastoid-like morphology* with a glass mouth pipette under a stereomicroscope for downstream experiments.</p><p><strong>*Note:</strong> Aggregates with the presence of an ICM-like compartment, a TE-like out layer, and a visible cavity are designated as blastoids.</p>"
                    }
                ]
            }
        ]
    }
]